Author Index Vol. 64, 2003
K. Kalbakis, Pat Ames, Massimo Di Maïo(University of Siena), Ch. Kouroussis, Howard H. Bailey, Hisamichi Aizawa, V. Labonia, Regina Deck, Gerardo Amabile, Sofia Agelaki(University of Crete), Francesco Nuzzo(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Simona Messinese(Ospedale Misericordia - Grosseto), Susana M. Campos(Dana-Farber Brigham Cancer Center), E. Karyda, Nikolaos Malamos(University of Patras), Roberto Petrioli(Azienda Ospedaliera Universitaria Senese), A. Alexopoulos, Daniele Pozzessere(Hospital of Prato), Emanuela Rossi(University of Milan), Marianna Sabatino, Shuichi Okada, Yuichiro Maéda(Nagoya University), Steven O’Day(Saint John's Health Center), C.L. Tiggelaar, Peter Vogt(Joint Research Centre), V. Georgoulias, Eric P. Winer(University of Vermont), Monika Jermann, Cesare Gridelli, Takuji Okusaka(National Cancer Centre Japan), A. De Matteis(Università Cattolica del Sacro Cuore), A. Ardavanis, Peter D. Boasberg(Angeles Clinic and Research Institute), Toshimitsu Saisho, Maureen Martin, Francesco Perrone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), H. Ueno(RIKEN), Akane Sano(Yokohama City University), Tim S. Kristedja, Gabriella Landi, Giuseppe D’Aiuto(Memorial Sloan Kettering Cancer Center), W. Gillis, K. Malas, H. Ian Robins(University of Wisconsin–Madison), Bernhard C. Pestalozzi(University of Zurich), E. Tselepatiotis, Kelly Shinn, S. Peters, Chigusa Morizane(Tokyo National Hospital)
Cited by 0
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
|New England Journal of Medicine|2013|3.4k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k